PRICE T ROWE ASSOCIATES INC /MD/ – Bristol-Myers Squibb Company Transaction History
PRICE T ROWE ASSOCIATES INC /MD/ portfolio value:
$432.61M
portfolio value
PRICE T ROWE ASSOCIATES INC /MD/ quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -58.28% | -8.50M shares | -690.58M | $71.09 | 6.08M |
| Q2 2022 | share | Decrease | -7.70% | -1.21M shares | -30.91M | $77 | 14.58M |
| Q1 2022 | share | Increase | +370.61% | 12.44M shares | 944.74M | $73.03 | 15.80M |
| Q4 2021 | share | Decrease | -13.88% | -541.19K shares | -21.34M | $62.52 | 3.35M |
| Q3 2021 | share | Increase | +9.11% | 325.66K shares | -8.06M | $59.17 | 3.89M |
| Q2 2021 | share | Decrease | -1.54% | -55.90K shares | 9.65M | $65.79 | 3.57M |
| Q1 2021 | share | Decrease | -7.77% | -305.65K shares | -14.96M | $62.15 | 3.62M |
| Q4 2020 | share | Decrease | -42.78% | -2.94M shares | -170.53M | $60.6 | 3.93M |
| Q3 2020 | share | Decrease | -20.43% | -1.76M shares | -93.60M | $58 | 6.87M |
| Q2 2020 | share | Decrease | -10.84% | -1.05M shares | -32.24M | $56.14 | 8.64M |
| Q1 2020 | share | Decrease | -13.16% | -1.46M shares | -176.11M | $52.79 | 9.69M |
| Q4 2019 | share | Decrease | -17.21% | -2.32M shares | 32.78M | $60.36 | 11.16M |
| Q3 2019 | share | Increase | +5.77% | 735.21K shares | 105.62M | $47.3 | 13.48M |
| Q2 2019 | share | Increase | +42.72% | 3.81M shares | 151.98M | $41.93 | 12.74M |
| Q1 2019 | share | Increase | +12.49% | 991.65K shares | 13.40M | $43.73 | 8.93M |
| Q4 2018 | share | Decrease | -28.93% | -3.23M shares | -280.91M | $47.21 | 7.94M |
| Q3 2018 | share | Increase | +5.33% | 565.25K shares | 106.59M | $56.02 | 11.17M |
| Q2 2018 | share | Decrease | -2.38% | -258.15K shares | -100.24M | $49.59 | 10.60M |
| Q1 2018 | share | Decrease | -10.99% | -1.34M shares | -60.85M | $56.31 | 10.86M |
| Q4 2017 | share | Decrease | -5.48% | -708.21K shares | -75.17M | $54.21 | 12.20M |
| Q3 2017 | share | Decrease | -4.16% | -560.83K shares | 72.35M | $56.04 | 12.91M |
| Q2 2017 | share | Decrease | -42.79% | -10.07M shares | -530.07M | $48.65 | 13.47M |
| Q1 2017 | call | Decrease | -100.00% | -2.56M shares | -149.60M | $47.14 | 0 |
| Q1 2017 | share | Decrease | -36.36% | -13.45M shares | -882.13M | $47.14 | 23.55M |
| Q4 2016 | call | Increase | 0.00% | 2.56M shares | 149.60M | $50.32 | 2.56M |
| Q4 2016 | share | Decrease | -18.00% | -8.12M shares | -270.67M | $50.32 | 37.01M |
| Q3 2016 | share | Decrease | -37.53% | -27.11M shares | -2.88B | $46.11 | 45.13M |
| Q2 2016 | share | Increase | +10.73% | 7.00M shares | 1.14B | $62.9 | 72.25M |
| Q1 2016 | share | Increase | +33.69% | 16.44M shares | 810.78M | $54.35 | 65.25M |